No abstract available
Publication types
-
Clinical Trial, Phase II
-
Multicenter Study
MeSH terms
-
Carcinoma, Non-Small-Cell Lung / mortality
-
Carcinoma, Non-Small-Cell Lung / pathology
-
Carcinoma, Non-Small-Cell Lung / therapy*
-
Combined Modality Therapy
-
Disease Progression
-
Dose Fractionation, Radiation
-
Dose-Response Relationship, Drug
-
Drug Administration Schedule
-
Erlotinib Hydrochloride
-
Fluorodeoxyglucose F18
-
Humans
-
Lung Neoplasms / mortality
-
Lung Neoplasms / pathology
-
Lung Neoplasms / therapy*
-
Neoplasm Staging
-
Positron-Emission Tomography
-
Prognosis
-
Prospective Studies
-
Quinazolines / therapeutic use*
-
Radiosurgery / methods*
-
Radiotherapy Dosage
-
Retreatment
-
Survival Rate
-
Treatment Failure
Substances
-
Quinazolines
-
Fluorodeoxyglucose F18
-
Erlotinib Hydrochloride